💨 Abstract

Stevanato Group SpA (STVN), based in Padua, reported a first-quarter profit of $27.9 million, or 11 cents per share, surpassing Wall Street expectations. Their revenue was $269.9 million, also exceeding forecasts. The company, known for producing glass vials for COVID-19 vaccines, projected full-year earnings of 53 to 57 cents per share, with revenue between $1.22

Courtesy: wtop.com

Summarized by Einstein Beta 🤖